Obstructive sleep apnea syndrome and asthma: The role of continuous positive airway pressure treatment

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 4, 2008, Pages 350-357

  Alkhalil, Michel ^a   Schulman, Edward S ^a   Getsy, Joanne ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ASTHMA; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE EXACERBATION; GASTROESOPHAGEAL REFLUX; HEART FUNCTION; HUMAN; MUSCLE FUNCTION; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP PATTERN; SMOOTH MUSCLE; THERAPY EFFECT; TREATMENT OUTCOME; WEIGHT CONTROL;

EID: 53549113943     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60309-2     Document Type: Review

References (80)

1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
2. Kyzer S, Charuzi I. Obstructive sleep apnea in the obese. World J Surg. 1988;22:998-1001.
3. Namen AM, Dunagan DP, Fleischer A, et al. Increased physician-reported sleep apnea: the national ambulatory medical care survey. Chest. 2002;121:1741-1747.
4. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 2007. NIH publication 08-4051.
5. Auckley D, Moallem M, Shaman Z, et al. Findings of a Berlin Questionnaire survey: comparison between patients seen in an asthma clinic versus internal medicine clinic. Sleep Med. 2008;9:494-499.
6. Ekici A, Ekici M, Kurtipek E, et al. Association of asthma-related symptoms with snoring and apnea and effect on health-related quality of life. Chest. 2005;128:3358-3363.
7. Teodorescu M, Consens FB, Bria WF, et al. Correlates of daytime sleepiness in patients with asthma. Sleep Med. 2006;7:607-613.
8. Ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26:812-818.
9. Hoffstein V, Viner S, Mateika S, et al. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure: patient compliance, perception of benefits, and side effects. Am Rev Respir Dis. 1992;145:841-845.
10. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis. 1988;137:1502-1504.
11. Guilleminault C, Quera-Salva MA, Powell N, et al. Nocturnal asthma: snoring, small pharynx and nasal CPAP. Eur Respir J. 1988;1:902-907.
12. Lafond C, Series F, Lemiere C. Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir. 2007;29:307-311.
13. Ciftci TU, Ciftci B, Guven SF, et al. Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med. 2005;99:529-534.
14. Bonay M, Nitenberg A, Maillard D. Should flow-volume loop be monitored in sleep apnea patients treated with continuous positive airway pressure? Respir Med. 2003;97:830-834.
15. Kaufman J, Wright G. The effect of nasal and nasopharyngeal irritation on airway resistance in man. Am Rev Respir Dis. 1969;100:826-830.
16. British Thoracic Society Standards of Care Committee. Non-invasive ventilation in acute respiratory failure. Thorax. 2002;57:192-211.
17. Wysocki M, Antonelli M. Noninvasive mechanical ventilation in acute hypoxaemic respiratory failure. Eur Respir J. 2001;18:209-220.
18. Wang CH, Lin HC, Huang TJ, et al. Differential effects of nasal continuous positive airway pressure on reversible or fixed upper and lower airway obstruction. Eur Respir J. 1996;9:952-959.
19. Cabanes L, Wener SN, Martran R, et al. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med. 1989;320:1317-1322.
20. Cabanes L, Costes F, Weber S, et al. Improvement in exercise performance by inhalation of methoxamine in patients with impaired left ventricular function. N Engl J Med. 1992;326:1661-1665.
21. Martin RJ, Pak J. Nasal CPAP in nonapneic nocturnal asthma. Chest. 1991;100:1024-1027.
22. Martin JG, Shore SA, Engel LA. Mechanical load and inspiratory muscle action during induced asthma. Am Rev Respir Dis. 1983;128:455-460.
23. Martin J, Shore S, Engel L. Effect of continuous positive airway pressure on respiratory mechanics and pattern of breathing in induced asthma. Am Rev Respir Dis. 1982;126:812-817.
24. Hyatt RE, Schilder DP, Fry DL. Relationship between maximum expiratory flow and degree of lung inflation. J Appl Physiol. 1958;13:331-336.
25. Verbraecken J, Willemen M, De Cock W, et al. Continuous positive airway pressure and lung inflation in sleep apnea patients. Respiration. 2001;68:357-364.
26. 2. J Appl Physiol. 1971;30:7-11.
27. Lopata M, Onal E. Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis. 1982;126:640-645.
28. Douglas FG, Chong PY. Influence of obesity on peripheral airways patency. J Appl Physiol. 1972;33:559-563.
29. Carr DT, Essex HE. Certain effects of positive pressure respiration on the circulatory and respiratory systems. Am Heart J. 1946;31:53-73.
30. Barach A, Swenson P. Effect of breathing gases under positive pressure on lumens of small and medium sized bronchi. Arch Intern Med. 1939;63:946-948.
31. Shivaram U, Miro AM, Cash ME, et al. Cardiopulmonary responses to continuous positive airway pressure in acute asthma. J Crit Care. 1993;8:87-92.
32. Gulleminault C, Lehrman AT, Forno L, Dement WC. Sleep apnoea syndrome: states of sleep and autonomic dysfunction. J Neurol Neurosurg Psychiatry. 1977;40:718-725.
33. Guilleminault C, Connolly S, Winkle R, Melvin K, Tilkian A. Cyclical variation of the heart rate in sleep apnea syndromes: mechanisms and usefulness of 24-hour electrocardiography as a screening technique. Lancet. 1984;i:126-136.
34. Nadel JA, Widdicombe JG. Reflex effects of upper airway irritation on total lung resistance and blood pressure. J Appl Physiol. 1962;17:861-865.
35. Denjean A, Canet E, Praud JP, et al. Hypoxia-induced bronchial responsiveness in awake sheep: role of carotid chemoreceptors. Respir Physiol. 1991;83:201-210.
36. Boushey HA, Holtzman MJ, Sheller JR, et al. Bronchial hyperreactivity. Am Rev Respir Dis. 1980;121:384-413.
37. Morrison JF, Pearson SB, Dean HG. Parasympathetic nervous system in nocturnal asthma. BMJ. 1988;296:1427-1429.
38. Morrison JF, Pearson SB. The parasympathetic nervous system and the diurnal variation of lung mechanics in asthma. Respir Med. 1991;85:285-289.
39. Ballard RD, Irvin CG, Martin RJ, et al. Influence of sleep on lung volumes in asthmatic patients and normal subjects. J Appl Physiol. 1990;68:2034-2041.
40. Desjardin JA, Sutarik JM, Suh BY, et al. Influence of sleep on pulmonary capillary volume in normal and asthmatic subjects. Am J Respir Crit Care Med. 1995;152:193-198.
41. Urata M, Fukuno H, Nomura M, et al. Gastric motility and autonomic activity during obstructive sleep apnea. Aliment Pharmacol Ther. 2006;24(suppl 4):132-140.
42. Kerr P, Shoenut JP, Steens RD, et al. Nasal continuous positive airway pressure: a new treatment for nocturnal gastroesophageal reflux? J Clin Gastroenterol. 1993;17:276-280.
43. Cibella F, Cuttitta G. Nocturnal asthma and gastroesophageal reflux. Am J Med. 2001;111(suppl 8A):31S-36S.
44. Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2006;173:1091-1097.
45. Field SK, Gelfand GA, McFadden SD. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest. 1999;116:766-774.
46. El-Solh AA, Mador MJ, Sikka P, et al. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest. 2002;121:1541-1547.
47. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129-1134.
48. Teramoto S, Yamamoto H, Ouchi Y. Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation. 2003;107:E40.
49. Devouassoux G, Levy P, Rossini E, et al. Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyperresponsiveness. J Allergy Clin Immunol. 2007;119:597-603.
50. Salerno FG, Carpagnano E, Guido P, et al. Airway inflammation in patients affected by obstructive sleep apnea syndrome. Respir Med. 2004;98:25-28.
51. Xu W, Chi L, Row BW, et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience. 2004;126:313-323.
52. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000;162:566-570.
53. Lavie L, Kraiczi H, Hefetz A, et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med. 2002;165:1624-1628.
54. Lee YC, Kwak YG, Song CH. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol. 2002;168:595-600.
55. Simcock DE, Kanabar V, Clarke GW, et al. Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am J Respir Crit Care Med. 2007;176:146-153.
56. Chen H, Tliba O, Van Besien CR, et al. TNF-α modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KCl. J Appl Physiol. 2003;95:864-872.
57. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med. 2004;169:361-366.
58. Snashall PD, Chung KF. Airway obstruction and bronchial hyperresponsiveness in left ventricular failure and mitral stenosis. Am Rev Respir Dis. 1991;144:945-956.
59. Brunnee T, Graf K, Kastens B, et al. Bronchial hyperreactivity in patients with moderate pulmonary circulation overload. Chest. 1993;103:1477-1481.
60. Borst MM, Beuthien W, Schwencke C, et al. Desensitization of the pulmonary adenylyl cyclase system: a cause of airway hyperresponsiveness in congestive heart failure? J Am Coll Cardiol. 1999;34:848-856.
61. Levin ER. Endothelins. N Engl J Med. 1995;333:356-363.
62. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348:1233-1241.
63. Huang L, Li C. Leptin: a multifunctional hormone. Cell Res. 2000;10:81-92.
64. Guler N, Kirerleri E, Ones U, Tamay Z, Salmayenli N, Darendeliler F. Leptin: does it have any role in childhood asthma? J Allergy Clin Immunol. 2004;114:254-259.
65. Wong CK, Cheung PF, Lam CW. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation. Eur J Immunol. 2007;37:2337-2348.
66. De Rosa V, Procaccini C, Cali G, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity. 2007;26:241-255.
67. Hersoug LG, Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy. 2007;62:1205-1213.
68. Shore SA, Rivera-Sanchez YM, Schwartzman IN, Johnston RA. Responses to ozone are increased in obese mice. J Appl Physiol. 2003;95:938-945.
69. Shore SA, Schwartzman IN, Mellema MS, et al. Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol. 2005;115:103-109.
70. Sin DD, Man SF. Impaired lung function and serum leptin in men and women with normal body weight: a population based study. Thorax. 2003;58:695-698.
71. Philips B, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2000;279:H234-H237.
72. Tatsumi K, Kasahara Y, Kurosu K, et al. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127:716-721.
73. Sanner B, Kollhossser P, Buechner N, et al. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J. 2004;23:601-604.
74. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;169:156-162.
75. Thomson CC, Clark S, Camargo CA Jr. Body mass index and asthma severity among adults presenting to the emergency department. Chest. 2003;124:795-802.
76. Shore SA, Fredberg JJ. Obesity, smooth muscle, and airway hyperresponsiveness. J Allergy Clin Immunol. 2005;115:925-927.
77. Stenius-Aarniala B, Poussa T, Kvarnstrom J, et al. Immediate and long term effects of weight reduction in obese people with asthma: randomized controlled study [published correction appears in BMJ. 2000;320:984]. BMJ. 2000;320:827-832.
78. Cooper BG, White JE, Ashworth LA, et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep. 1995;18:172-179.
79. Ballard RD, Tan WC, Kelly PL, et al. Effect of sleep and sleep deprivation on ventilatory response to bronchoconstriction. J Appl Physiol. 1990;69:490-497.
80. Dinges DF, Maislin G, Staley B, et al. Sleepiness and neurobehavioral functioning in relation in apnea severity in a cohort of commercial motor vehicle operators. Sleep. 1998;21(suppl):83.